This meta-analysis showed that daprodustat maintained the same efficacy in increasing Hb levels in both DD-CKD and NDD-CKD as ESAs; however, daprodustat significantly lowered hepcidin levels and increased TIBC in both groups in comparison with ESAs. The gene discussed is HAMP; the disease is chronic kidney disease.